Authors:
DEVLIN JW
BENMENACHEM T
ULEP SK
PETERS MJ
FOGEL RP
ZAROWITZ BJ
Citation: Jw. Devlin et al., STRESS-ULCER PROPHYLAXIS IN MEDICAL ICU PATIENTS - ANNUAL UTILIZATIONIN RELATION TO THE INCIDENCE OF ENDOSCOPICALLY PROVEN STRESS ULCERATION, The Annals of pharmacotherapy, 32(9), 1998, pp. 869-874
Authors:
JOY MS
MATZKE GR
ARMSTRONG DK
MARX MA
ZAROWITZ BJ
Citation: Ms. Joy et al., A PRIMER ON CONTINUOUS RENAL REPLACEMENT THERAPY FOR CRITICALLY ILL PATIENTS, The Annals of pharmacotherapy, 32(3), 1998, pp. 362-375
Citation: Mi. Rudis et al., PERIPHERAL-NERVE STIMULATION AND CLINICAL-ASSESSMENT FOR DOSING OF NEUROMUSCULAR BLOCKING-AGENTS IN CRITICALLY ILL PATIENTS - REPLY, Critical care medicine, 26(4), 1998, pp. 805-805
Citation: El. Peterson et al., DOES TRAIN-OF-FOUR MONITORING REDUCE RECOVERY-TIME AFTER NEUROMUSCULAR BLOCKADE - THE AUTHORS REPLY, Critical care medicine, 26(11), 1998, pp. 1920-1920
Authors:
ZAROWITZ BJ
RUDIS MI
LAI K
PETITTA A
LULEK M
Citation: Bj. Zarowitz et al., RETROSPECTIVE PHARMACOECONOMIC EVALUATION OF DOSING VECURONIUM BY PERIPHERAL-NERVE STIMULATION VERSUS STANDARD CLINICAL-ASSESSMENT IN CRITICALLY-ILL PATIENTS, Pharmacotherapy, 17(2), 1997, pp. 327-332
Authors:
RUDIS MI
SIKORA CA
ANGUS E
PETERSON E
POPOVICH J
HYZY R
ZAROWITZ BJ
Citation: Mi. Rudis et al., A PROSPECTIVE, RANDOMIZED, CONTROLLED EVALUATION OF PERIPHERAL-NERVE STIMULATION VERSUS STANDARD CLINICAL DOSING OF NEUROMUSCULAR BLOCKING-AGENTS IN CRITICALLY ILL PATIENTS, Critical care medicine, 25(4), 1997, pp. 575-583
Authors:
RUDIS MI
AUCLAIR B
ZAROWITZ BJ
DUCHARME MP
Citation: Mi. Rudis et al., POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF VECURONIUM(V) IN CRITICALLY ILL PATIENTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 65-65
Citation: Ve. Mlynarek et al., PREDICTING UNBOUND PHENYTOIN CONCENTRATIONS IN THE CRITICALLY ILL NEUROSURGICAL PATIENT, The Annals of pharmacotherapy, 30(3), 1996, pp. 219-223
Citation: Mi. Rudis et al., TECHNICAL AND INTERPRETIVE PROBLEMS OF PERIPHERAL-NERVE STIMULATION IN MONITORING NEUROMUSCULAR BLOCKADE IN THE INTENSIVE-CARE UNIT, The Annals of pharmacotherapy, 30(2), 1996, pp. 165-172
Citation: Me. Mlynarek et al., PREDICTING UNBOUND PHENYTOIN CONCENTRATIONS IN THE CRITICALLY ILL NEUROSURGICAL PATIENT - REPLY, The Annals of pharmacotherapy, 30(10), 1996, pp. 1200-1201
Authors:
ZAROWITZ BJ
NAPPI J
DUKES GE
CARTER BL
BOUCHER BA
BUSSEY HI
HAK LJ
HARDIN TC
LAKE KD
OCONNELL MB
WELLS BG
ELENBAAS RM
KIRK JK
MICHAEL KA
MARKOWSKY SJ
RESTINO MR
Citation: Bj. Zarowitz et al., CRITICAL PATHWAYS - THE TIME IS HERE FOR PHARMACIST INVOLVEMENT, Pharmacotherapy, 16(4), 1996, pp. 723-733
Authors:
TISDALE JE
RUDIS MI
PADHI ID
BORZAK S
SVENSSON CK
WEBB CR
ACCIAIOLI J
WARE JA
KREPOSTMAN A
ZAROWITZ BJ
Citation: Je. Tisdale et al., DISPOSITION OF PROCAINAMIDE IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE RECEIVING MEDICAL THERAPY, Journal of clinical pharmacology, 36(1), 1996, pp. 35-41
Authors:
BENMENACHEM T
MCCARTHY BD
FOGEL R
SCHIFFMAN RM
PATEL RV
ZAROWITZ BJ
NERENZ DR
BRESALIER RS
Citation: T. Benmenachem et al., PROPHYLAXIS FOR STRESS-RELATED GASTROINTESTINAL HEMORRHAGE - A COST-EFFECTIVENESS ANALYSIS, Critical care medicine, 24(2), 1996, pp. 338-345
Authors:
PATEL RV
PETERSON EL
SILVERMAN N
ZAROWITZ BJ
Citation: Rv. Patel et al., ESTIMATION OF TOTAL-BODY AND EXTRACELLULAR WATER IN POST-CORONARY ARTERY BYPASS GRAFT SURGICAL PATIENTS USING SINGLE AND MULTIPLE FREQUENCYBIOIMPEDANCE, Critical care medicine, 24(11), 1996, pp. 1824-1828
Authors:
RUDIS MI
GUSLITS BJ
PETERSON EL
HATHAWAY SJ
ANGUS E
BEIS S
ZAROWITZ BJ
Citation: Mi. Rudis et al., ECONOMIC-IMPACT OF PROLONGED MOTOR WEAKNESS COMPLICATING NEUROMUSCULAR BLOCKADE IN THE INTENSIVE-CARE UNIT, Critical care medicine, 24(10), 1996, pp. 1749-1756
Citation: Bj. Zarowitz, BIOELECTRICAL-IMPEDANCE ANALYSIS MEASUREMENTS FOR DRUG PHARMACOKINETICS, The American journal of clinical nutrition, 64(3), 1996, pp. 519-523
Authors:
TOUCHETTE MA
PATEL RV
ANANDAN JV
DUMLER F
ZAROWITZ BJ
Citation: Ma. Touchette et al., VANCOMYCIN REMOVAL BY HIGH-FLUX POLYSULFONE HEMODIALYSIS MEMBRANES INCRITICALLY ILL PATIENTS WITH END-STAGE RENAL-DISEASE, American journal of kidney diseases, 26(3), 1995, pp. 469-474
Authors:
TISDALE JE
RUDIS MI
PADHI ID
SVENSSON CK
WEBB CR
BORZAK S
WARE JA
KREPOSTMAN A
ZAROWITZ BJ
Citation: Je. Tisdale et al., INHIBITION OF N-ACETYLATION OF PROCAINAMIDE AND RENAL CLEARANCE OF N-ACETYLPROCAINAMIDE BY PARA-AMINOBENZOIC ACID IN HUMANS, Journal of clinical pharmacology, 35(9), 1995, pp. 902-910
Authors:
TISDALE JE
PATEL R
WEBB CR
BORZAK S
ZAROWITZ BJ
Citation: Je. Tisdale et al., ELECTROPHYSIOLOGIC AND PROARRHYTHMIC EFFECTS OF INTRAVENOUS INOTROPICAGENTS, Progress in cardiovascular diseases, 38(2), 1995, pp. 167-180
Authors:
TISDALE JE
RUDIS MI
PADHI ID
BORZAK S
SVENSSON CK
WEBB CR
WARE JA
KREPOSTMAN A
ZAROWITZ BJ
Citation: Je. Tisdale et al., PROCAINAMIDE (PA) PHARMACOKINETICS IN CONGESTIVE-HEART-FAILURE (CHF), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 142-142
Authors:
TISDALE JE
RUDIS MI
PADHI ID
SVENSSON CK
WEBB CR
BORZAK S
WARE JA
KREPOSTMAN A
ZAROWITZ BJ
Citation: Je. Tisdale et al., INHIBITION OF PROCAINAMIDE (PA) N-ACETYLATION BY PARA-AMINOBENZOIC ACID (PABA), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 184-184